Pulmonary Hypertension (PH) Terminated Phase 3 Trials for Ambrisentan (DB06403)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00879229ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTreatment